TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MGTX

MeiraGTx Holdings PLC

Healthcare · Biotechnology

11.10$ -6.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MGTX
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
84.7% 44.4% 77.0% 83.0% 74.9% 57.2% 48.5% 48.9% 45.8% 37.5%
77.5% 33.1% 70.3% 70.2% 57.6% 43.0% 36.3% 39.7% 38.4% 27.0%
77.5% 33.1% 70.3% 70.2% 57.6% 43.0% 36.3% 39.7% 38.4% 27.0%
– – 4.7% 11.5% 15.2% 10.9% 9.1% 7.2% 3.9% 7.5%
– – – 1.4% 1.9% 2.5% 2.6% 0.0% 0.1% 0.0%
12.5% 54.5% 22.7% 16.3% 12.1% 39.4% 34.3% – – –
– – – 0.2% 0.8% 0.8% 0.7% 0.3% 0.3% 0.2%
176.0% 283.2% 16.3% 41.1% 34.4% 42.1% 63.0% 57.7% 74.9% 102.4%
26.8% 82.8% 16.0% 15.2% 14.9% 21.3% 25.8% 20.5% 22.5% 50.1%
0.0% 5.7% 0.0% 0.5% 0.7% 1.1% 1.2% 1.3% 1.5% 11.3%
6.5% 27.3% 3.1% 1.2% 2.0% 4.8% 5.2% 4.9% 8.7% 4.1%
0.0% 0.1% – – – 0.3% 22.4% 22.1% 27.1% 20.3%
-76.0% -183.2% 83.7% 58.9% 65.6% 57.9% 37.0% 42.3% 25.1% -2.4%
-152.5% -253.0% -153.0% -62.7% -71.8% -106.4% -147.8% -169.6% -260.2% -333.9%
85.3% 33.2% 19.6% 10.2% 10.4% 13.8% 14.2% 17.3% 25.9% 32.9%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?